BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9682278)

  • 1. A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus.
    Helsley S; Fiorella D; Rabin RA; Winter JC
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):649-63. PubMed ID: 9682278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
    Gatch MB; Rutledge MA; Carbonaro T; Forster MJ
    Psychopharmacology (Berl); 2009 Jul; 204(4):715-24. PubMed ID: 19288085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of beta-carbolines in rats trained with ibogaine as a discriminative stimulus.
    Helsley S; Rabin RA; Winter JC
    Eur J Pharmacol; 1998 Mar; 345(2):139-43. PubMed ID: 9600629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of N,N-diisopropyltryptamine.
    Carbonaro TM; Forster MJ; Gatch MB
    Psychopharmacology (Berl); 2013 Mar; 226(2):241-6. PubMed ID: 23070023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
    Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA
    Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abuse liability profile of three substituted tryptamines.
    Gatch MB; Forster MJ; Janowsky A; Eshleman AJ
    J Pharmacol Exp Ther; 2011 Jul; 338(1):280-9. PubMed ID: 21474568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens.
    Winter JC; Helsley S; Fiorella D; Rabin RA
    Pharmacol Biochem Behav; 1999 Jul; 63(3):507-13. PubMed ID: 10418794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance and limited cross-tolerance to the effects of N, N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat.
    Kovacic B; Domino EF
    J Pharmacol Exp Ther; 1976 Jun; 197(3):495-502. PubMed ID: 1064726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of partial LSD analogs with behavioral disrupting effects of LSD and DMT in the rat.
    Kovacic B; Wang Lu LJ; Ruffing D; Domino EF
    Eur J Pharmacol; 1978 Jan; 47(1):37-44. PubMed ID: 271075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.
    Rabin RA; Regina M; Doat M; Winter JC
    Pharmacol Biochem Behav; 2002 May; 72(1-2):29-37. PubMed ID: 11900766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.
    Blair JB; Marona-Lewicka D; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
    J Med Chem; 1999 Mar; 42(6):1106-11. PubMed ID: 10090793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of DOM and DMT in a proposed animal model of hallucinogenic activity.
    Adams LM; Geyer MA
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):121-32. PubMed ID: 3858911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selected opioid agonists and antagonists on DMT- and LSD-25-induced disruption of food-rewarded bar pressing behavior in the rat.
    Ruffing DM; Domino EF
    Psychopharmacology (Berl); 1981; 75(3):226-30. PubMed ID: 6798611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat.
    Ruffing D; Kovacic B; Demetriou S; Domino EF
    Psychopharmacology (Berl); 1979 Apr; 62(3):207-10. PubMed ID: 111285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.
    Fiorella D; Palumbo PA; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 May; 119(2):239-45. PubMed ID: 7659772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies on the mode of action of psychotomimetic drugs: antagonism of the excitatory actions of 5-hydroxytryptamine by methylated derivatives of tryptamine.
    Bradley PB; Briggs I
    Br J Pharmacol; 1974 Mar; 50(3):345-54. PubMed ID: 4277490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.
    Carbonaro TM; Eshleman AJ; Forster MJ; Cheng K; Rice KC; Gatch MB
    Psychopharmacology (Berl); 2015 Jan; 232(1):275-84. PubMed ID: 24985890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic mediation of tetrahydro-beta-carboline.
    Schechter MD
    Pharmacol Biochem Behav; 1986 May; 24(5):1209-13. PubMed ID: 3725827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.
    Fantegrossi WE; Reissig CJ; Katz EB; Yarosh HL; Rice KC; Winter JC
    Pharmacol Biochem Behav; 2008 Jan; 88(3):358-65. PubMed ID: 17905422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.